Shiba Inu (SHIB) Team Warned Them, But They Didn_t Listen: CAL Token Drama

2023-09-22 12:45:52

Shiba Inu developer Kaal Dhairya issued a stark warning to investors to refrain from trading services with the memecoin Calcium (CAL)

The asset saw the light of day earlier today (September 22) and quickly amassed a market capitalization of almost $4 million. Its price performance, though, went on a downtrend in the following hours.

The Reason Behind CAL’s Launch

Kaal Dhairya took it to X (Twitter) to remind users that Calcium token (CAL) was created “only for the specific purpose to mint and renounce BONE.” As such, they ed it will not have any future value, meaning people should not conduct trading services with it. “If someone is selling this, please consider this as scam,” the developer concluded.

As previously mentioned in the screenshot below, we are in the process of renouncing BONE. Please do not buy or trade the Calcium token (seriously), there is no liquidity and claims of large losses are FUD. PLEASE READ : pic.twitter.com/1pxoaK4A12

— Kaal (@kaaldhairya) September 21, 2023

The pseudonymous X user “Shib Informer”issueda similar warning, telling their followers that CAL is for “internal use” and not for trading.

The Latest Memecoin to Hit the Market

Depicted as a “dummy” token, Calcium (CAL) is among the latest memecoins to enter the vast crypto realm. It is deployed by the Shiba Inu team and aims to accelerate the advancement of BONE (the native asset of the ShibaSwap decentralized exchange)

Currently, there are hundreds of memecoins, with the first one – Dogecoin (DOGE) – seeing the light of day in 2013. Those who wish to learn more about those assets, understand their characteristics, and whether they are safe to invest in can watch our dedicated video:

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.